Vincristine sulfate liposomal injection for acute lymphoblastic leukemia

Código QR

Vincristine sulfate liposomal injection for acute lymphoblastic leukemia

Trisha A Soosay Raj,1 Amanda M Smith,2 Andrew S Moore,1,21Royal Children's Hospital, Children's Health Queensland Hospital and Health Service, Brisbane, Queensland, Australia; 2Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, QLD, Aust...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Soosay Raj TA, Smith AM, Moore AS
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/d32dd0b169144dda9a57652f7329c9f5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Vincristine sulfate liposomal injection for acute lymphoblastic leukemia [Corrigendum]
por: Soosay Raj TA, et al.
Publicado: (2013)

Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine
por: Davis T, et al.
Publicado: (2013)

The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate
por: Zhang J, et al.
Publicado: (2016)

Delivery of vincristine sulfate-conjugated gold nanoparticles using liposomes: a light-responsive nanocarrier with enhanced antitumor efficiency
por: Liu Y, et al.
Publicado: (2015)

First-line treatment of acute lymphoblastic leukemia with pegasparaginase
por: Riccardo Masetti, et al.
Publicado: (2009)

Development of a stable single-vial liposomal formulation for vincristine
por: Mao W, et al.
Publicado: (2019)

Nonspecifically enhanced therapeutic effects of vincristine on multidrug-resistant cancers when coencapsulated with quinine in liposomes
por: Xu YZ, et al.
Publicado: (2015)

Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia
por: Abuasab T, et al.
Publicado: (2021)

Evaluation of Nitric Oxide production by monocytes in children with acute lymphoblastic leukemia
por: R Chegeni, et al.
Publicado: (2001)

Eruptive acral lentiginosis following chemotherapy for acute lymphoblastic leukemia: A case series
por: Cathal O’Connor, et al.
Publicado: (2021)

B- Acute Lymphoblastic Leukemia L2 In Second Trimester of Pregnancy
por: Iraisa rosaria, et al.
Publicado: (2021)

Therapeutic developments in acute lymphoblastic leukemia
por: MacKenzie A, et al.
Publicado: (2012)

ASSOCIATION OF HYPERDIPLOIDY WITH REMISSION STATUS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA AFTER INDUCTION THERAPY
por: Saqib Hussain Korejo, et al.
Publicado: (2019)

Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia [Corrigendum]
por: Wu X, et al.
Publicado: (2018)

FREQUENCY OF DRUG INDUCED HYPERGLYCEMIA DURING REMISSION INDUCTION THERAPY IN ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
por: Abdul Ali Wajid, et al.
Publicado: (2018)

Is there a role for B lymphocyte chimerism in the monitoring of B-acute lymphoblastic leukemia patients receiving allogeneic stem cell transplantation?
por: Yi-Ning Yang, et al.
Publicado: (2015)

Emerging treatment approaches in acute lymphoblastic and acute myeloid leukemias
por: Thomas X
Publicado: (2012)

NOTCH-ing up nucleotide metabolism in T-cell acute lymphoblastic leukemia
por: Andrew Volk
Publicado: (2021)

Preparation, Characterization, Pharmacokinetic, and Therapeutic Potential of Novel 6-Mercaptopurine-Loaded Oral Nanomedicines for Acute Lymphoblastic Leukemia
por: Zou Y, et al.
Publicado: (2021)

REMISSION RATE OF PRE-B ALL (ACUTE LYMPHOBLASTIC LEUKEMIA) AFTER INDUCTION CHEMOTHERAPY FOLLOWING UNITED KINGDOM ACUTE LYMPHOBLASTIC LEUKAEMIA 2011 (UKALL 2011) TRIAL PROTOCOL
por: Hafiz Muhammad Murtaza, et al.
Publicado: (2021)

Garlic compounds selectively kill childhood pre-B acute lymphoblastic leukemia cells in vitro without reducing T-cell function: Potential therapeutic use in the treatment of ALL
por: Greg Hodge, et al.
Publicado: (2008)

Thiol-Reactive Star Polymers Functionalized with Short Ethoxy-Containing Moieties Exhibit Enhanced Uptake in Acute Lymphoblastic Leukemia Cells
por: Bayat N, et al.
Publicado: (2019)

T-Cell Acute Lymphoblastic Leukemia—Current Concepts in Molecular Biology and Management
por: Parveen Shiraz, et al.
Publicado: (2021)

POST-TREATMENT NUTRITIONAL STATUS OF CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
por: Akbar Akbarov, et al.
Publicado: (2021)

BONE AS A SITE OF EXTRAMEDULLARY DISEASE IN ACUTE LYMPHOBLASTIC LEUKEMIA
por: Fatma Tuba YILDIRIM, et al.
Publicado: (2021)

FEATURES OF IMMUNE CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA
por: O. V. Smirnova, et al.
Publicado: (2014)

The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals
por: Men Y, et al.
Publicado: (2011)

Blinatumomab for the Treatment of Adult B-Cell Acute Lymphoblastic Leukemia: Toward a New Era of Targeted Immunotherapy
por: Franquiz MJ, et al.
Publicado: (2020)

An Attention-Based Convolutional Neural Network for Acute Lymphoblastic Leukemia Classification
por: Muhammad Zakir Ullah, et al.
Publicado: (2021)

Biomarkers of cardiometabolic complications in survivors of childhood acute lymphoblastic leukemia
por: Sophia Morel, et al.
Publicado: (2020)

Survival of adults with acute lymphoblastic leukemia in Germany and the United States.
por: Dianne Pulte, et al.
Publicado: (2014)

Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential
por: Yu Y, et al.
Publicado: (2017)

Use of clofarabine for acute childhood leukemia
por: A Pession, et al.
Publicado: (2010)

Role of L-asparaginase in acute lymphoblastic leukemia: focus on adult patients
por: Rytting ME
Publicado: (2012)

Profile of inotuzumab ozogamicin and its potential in the treatment of acute lymphoblastic leukemia
por: Thomas X
Publicado: (2014)

BONE MARROW NECROSIS IN ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE REPORT
por: Melike Nur Ünal, et al.
Publicado: (2021)

Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia
por: Wu X, et al.
Publicado: (2017)

The influence of MTHFR genetic polymorphisms on methotrexate therapy in pediatric acute lymphoblastic leukemia
por: Shen Yaqing, et al.
Publicado: (2021)

FUNCTIONAL ACTIVITY OF NEUTROPHILS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
por: T. G. Kadricheva, et al.
Publicado: (2014)

Profound leukemia cutis in a patient with relapsed T-cell acute lymphoblastic leukemia
por: Ambika Nohria, BA, et al.
Publicado: (2021)